July 3rd 2025
Why future-ready pharma companies must embrace AI-driven, real-time decision-making.
Vera Pomerantseva of eClinical Solutions Reacts to FDA’s Recent Protocol Deviations Guidance
February 25th 2025In this video interview, Pomerantseva, director of product management, RBQM, eClinical Solutions, discusses the new guidance and its level of detail on the different types of protocol deviations.
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
December 6th 2024Palmese, executive director, site relationships and DCT solutions, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.
Master Protocols: Implementing Effective Treatment Adaptations in the Randomization
August 23rd 2023It is unrealistic to include infinite adaptations in an IRT system, thus identifying the optimal level of adaptations requires examination of the study’s characteristics and planning phase considerations.